Last 12 months
Inside the activity.
0 purchase rows · 93 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 16 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 49 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 02, 2022 Filed May 4, 2022 21:21 UTC |
Arbuckle Stuart AEVP, COO
|
SaleCommon Stock | 306 | $263.98 | $80,777.88 |
DisclosureSEC source: 0000899243-22-016653 · doc4.xml · nonDerivative · entry 1 Arbuckle Stuart A · CIK 0001557290 · EVP, COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,760 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. Read SEC document |
| May 01, 2022 Filed May 3, 2022 20:42 UTC |
Garber Alan MDirector
|
GrantStock Option (Right to Buy) · Derivative | 4,462 | $0.00 Strike: $276.17 | $0.00 |
DisclosureSEC source: 0000899243-22-016329 · doc4.xml · derivative · entry 1 Garber Alan M · CIK 0001312907 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,462 Underlying: Common Stock · 4,462 shares Expires 2032-04-30 Read SEC document |
| May 01, 2022 Filed May 3, 2022 20:43 UTC |
SACHS BRUCE IDirector
|
GrantStock Option (Right to Buy) · Derivative | 4,462 | $0.00 Strike: $276.17 | $0.00 |
DisclosureSEC source: 0000899243-22-016331 · doc4.xml · derivative · entry 1 SACHS BRUCE I · CIK 0001197036 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,462 Underlying: Common Stock · 4,462 shares Expires 2032-04-30 Read SEC document |
| May 01, 2022 Filed May 3, 2022 20:44 UTC |
CARNEY LLOYDDirector
|
GrantCommon Stock | 1,449 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-016332 · doc4.xml · nonDerivative · entry 1 CARNEY LLOYD · CIK 0001204424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,850 F1 · shares: Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date. Read SEC document |
| May 01, 2022 Filed May 3, 2022 20:47 UTC |
MCGLYNN MARGARET GDirector
|
GrantStock Option (Right to Buy) · Derivative | 4,462 | $0.00 Strike: $276.17 | $0.00 |
DisclosureSEC source: 0000899243-22-016336 · doc4.xml · derivative · entry 3 MCGLYNN MARGARET G · CIK 0001215126 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,462 Underlying: Common Stock · 4,462 shares Expires 2032-04-30 Read SEC document |
| May 01, 2022 Filed May 3, 2022 20:47 UTC |
MCGLYNN MARGARET GDirector
|
GrantDeferred Stock Units · Derivative | 921 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-016336 · doc4.xml · derivative · entry 2 MCGLYNN MARGARET G · CIK 0001215126 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,609 Underlying: Common Stock · 921 shares Expires not disclosed F2 · derivative.exercise_price: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McGlynn's service on the Issuer's board of directors, (ii) a change of control of the Issuer and (iii) Ms. McGlynn's disability or death. F1 · price: Upon the vesting of restricted stock units granted to Ms. McGlynn on May 1, 2021, Ms. McGlynn deferred the receipt of 921 shares of common stock and received instead 921 deferred stock units pursuant to the Issuer's deferred compensation plan. As a result, Ms. McGlynn is reporting the disposition of 921 shares of common stock in exchange for an equal number of deferred stock units. F2 · derivative.exercise_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McGlynn's service on the Issuer's board of directors, (ii) a change of control of the Issuer and (iii) Ms. McGlynn's disability or death. F2 · derivative.expiration_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McGlynn's service on the Issuer's board of directors, (ii) a change of control of the Issuer and (iii) Ms. McGlynn's disability or death. Read SEC document |
| May 01, 2022 Filed May 3, 2022 20:47 UTC |
MCGLYNN MARGARET GDirector
|
Disposition to issuerCommon Stock | 921 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-016336 · doc4.xml · nonDerivative · entry 1 MCGLYNN MARGARET G · CIK 0001215126 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178 F1 · price: Upon the vesting of restricted stock units granted to Ms. McGlynn on May 1, 2021, Ms. McGlynn deferred the receipt of 921 shares of common stock and received instead 921 deferred stock units pursuant to the Issuer's deferred compensation plan. As a result, Ms. McGlynn is reporting the disposition of 921 shares of common stock in exchange for an equal number of deferred stock units. Read SEC document |
| May 01, 2022 Filed May 3, 2022 20:47 UTC |
Bhatia Sangeeta N.Director
|
GrantCommon Stock | 1,449 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-016337 · doc4.xml · nonDerivative · entry 1 Bhatia Sangeeta N. · CIK 0001643921 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,640 F1 · shares: Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date. Read SEC document |
| May 01, 2022 Filed May 3, 2022 20:48 UTC |
MCKENZIE DIANADirector
|
GrantDeferred Stock Units · Derivative | 1,842 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-016338 · doc4.xml · derivative · entry 4 MCKENZIE DIANA · CIK 0001754648 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,730.685 Underlying: Common Stock · 1,842 shares Expires not disclosed F2 · derivative.exercise_price: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on the Issuer's board of directors, (ii) a change of control of the Issuer and (iii) Ms. McKenzie's disability or death. F1 · price: Upon the vesting of restricted stock units granted to Ms. McKenzie on May 1, 2021, Ms. McKenzie deferred the receipt of 1,842 shares of common stock and received instead 1,842 deferred stock units pursuant to the Issuer's deferred compensation plan. As a result, Ms. McKenzie is reporting the disposition of 1,842 shares of common stock in exchange for an equal number of deferred stock units. F2 · derivative.exercise_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on the Issuer's board of directors, (ii) a change of control of the Issuer and (iii) Ms. McKenzie's disability or death. F2 · derivative.expiration_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on the Issuer's board of directors, (ii) a change of control of the Issuer and (iii) Ms. McKenzie's disability or death. Read SEC document |
| May 01, 2022 Filed May 3, 2022 20:48 UTC |
MCKENZIE DIANADirector
|
GrantCommon Stock | 1,449 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-016338 · doc4.xml · nonDerivative · entry 2 MCKENZIE DIANA · CIK 0001754648 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,884 F3 · shares: Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date. Read SEC document |
| May 01, 2022 Filed May 3, 2022 20:48 UTC |
MCKENZIE DIANADirector
|
Disposition to issuerCommon Stock | 1,842 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-016338 · doc4.xml · nonDerivative · entry 1 MCKENZIE DIANA · CIK 0001754648 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,435 F1 · price: Upon the vesting of restricted stock units granted to Ms. McKenzie on May 1, 2021, Ms. McKenzie deferred the receipt of 1,842 shares of common stock and received instead 1,842 deferred stock units pursuant to the Issuer's deferred compensation plan. As a result, Ms. McKenzie is reporting the disposition of 1,842 shares of common stock in exchange for an equal number of deferred stock units. Read SEC document |
| May 01, 2022 Filed May 3, 2022 20:53 UTC |
Lee YuchunDirector
|
GrantStock Option (Right to Buy) · Derivative | 4,462 | $0.00 Strike: $276.17 | $0.00 |
DisclosureSEC source: 0000899243-22-016342 · doc4.xml · derivative · entry 1 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,462 Underlying: Common Stock · 4,462 shares Expires 2032-04-30 Read SEC document |
| May 01, 2022 Filed May 3, 2022 21:41 UTC |
Kearney Terrence CDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,231 | $0.00 Strike: $276.17 | $0.00 |
DisclosureSEC source: 0000899243-22-016384 · doc4.xml · derivative · entry 2 Kearney Terrence C · CIK 0001289098 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,231 Underlying: Common Stock · 2,231 shares Expires 2032-04-30 Read SEC document |
| May 01, 2022 Filed May 3, 2022 21:41 UTC |
Kearney Terrence CDirector
|
GrantCommon Stock | 725 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-016384 · doc4.xml · nonDerivative · entry 1 Kearney Terrence C · CIK 0001289098 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,536 F1 · shares: Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date. Read SEC document |
| April 29, 2022 Filed May 3, 2022 20:26 UTC |
Sanna BastianoEVP, Cell & Genetic Therapies
|
Tax withholdingCommon Stock | 766 | $276.17 | $211,546.22 |
DisclosureSEC source: 0000899243-22-016316 · doc4.xml · nonDerivative · entry 1 Sanna Bastiano · CIK 0001829069 · EVP, Cell & Genetic Therapies 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,016 Read SEC document |
| April 29, 2022 Filed May 3, 2022 20:27 UTC |
WAGNER CHARLES F JREVP & Chief Financial Officer
|
Tax withholdingCommon Stock | 547 | $276.17 | $151,064.99 |
DisclosureSEC source: 0000899243-22-016318 · doc4.xml · nonDerivative · entry 1 WAGNER CHARLES F JR · CIK 0001223348 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,073 Read SEC document |
| April 29, 2022 Filed May 3, 2022 20:28 UTC |
Liu JoySVP, General Counsel
|
SaleCommon Stock | 10 | $278.04 | $2,780.40 |
DisclosureSEC source: 0000899243-22-016320 · doc4.xml · nonDerivative · entry 5 Liu Joy · CIK 0001847529 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,334 F1 · kind: Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1. Read SEC document |
| April 29, 2022 Filed May 3, 2022 20:28 UTC |
Liu JoySVP, General Counsel
|
SaleCommon Stock | 22 | $276.72 | $6,087.84 |
DisclosureSEC source: 0000899243-22-016320 · doc4.xml · nonDerivative · entry 4 Liu Joy · CIK 0001847529 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,344 F1 · kind: Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1. F2 · price: Ms. Liu undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $276.72 (range $276.31 to $277.06). Read SEC document |
| April 29, 2022 Filed May 3, 2022 20:28 UTC |
Liu JoySVP, General Counsel
|
SaleCommon Stock | 30 | $275.62 | $8,268.60 |
DisclosureSEC source: 0000899243-22-016320 · doc4.xml · nonDerivative · entry 3 Liu Joy · CIK 0001847529 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,366 F1 · kind: Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1. F2 · price: Ms. Liu undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $275.62 (range $275.22 to $276.19). Read SEC document |
| April 29, 2022 Filed May 3, 2022 20:28 UTC |
Liu JoySVP, General Counsel
|
SaleCommon Stock | 41 | $274.75 | $11,264.75 |
DisclosureSEC source: 0000899243-22-016320 · doc4.xml · nonDerivative · entry 2 Liu Joy · CIK 0001847529 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,396 F1 · kind: Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1. F2 · price: Ms. Liu undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $274.74 (range $274.20 to $275.14). Read SEC document |
| April 29, 2022 Filed May 3, 2022 20:28 UTC |
Liu JoySVP, General Counsel
|
SaleCommon Stock | 17 | $273.37 | $4,647.29 |
DisclosureSEC source: 0000899243-22-016320 · doc4.xml · nonDerivative · entry 1 Liu Joy · CIK 0001847529 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,437 F1 · kind: Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1. F2 · price: Ms. Liu undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price. F3 · price: Open market sales reported on this line occurred at a weighted average price of $273.37 (range $273.13 to $273.87). Read SEC document |
| April 25, 2022 Filed Apr 27, 2022 20:05 UTC |
Ambrose KristenSVP & Chief Accounting Officer
|
SaleCommon Stock | 104 | $271.68 | $28,254.72 |
DisclosureSEC source: 0000899243-22-015762 · doc4.xml · nonDerivative · entry 4 Ambrose Kristen · CIK 0001856587 · SVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,496 F1 · kind: Transaction made pursuant to Ms. Ambrose's company approved trading plan under Rule 10b5-1. F2 · price: Ms. Ambrose undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $271.68 (range $271.25 to $272.23). Read SEC document |
| April 25, 2022 Filed Apr 27, 2022 20:05 UTC |
Ambrose KristenSVP & Chief Accounting Officer
|
SaleCommon Stock | 83 | $269.51 | $22,369.33 |
DisclosureSEC source: 0000899243-22-015762 · doc4.xml · nonDerivative · entry 3 Ambrose Kristen · CIK 0001856587 · SVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,600 F1 · kind: Transaction made pursuant to Ms. Ambrose's company approved trading plan under Rule 10b5-1. F2 · price: Ms. Ambrose undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $269.51 (range $269.12 to $269.90). Read SEC document |
| April 25, 2022 Filed Apr 27, 2022 20:05 UTC |
Ambrose KristenSVP & Chief Accounting Officer
|
SaleCommon Stock | 80 | $268.46 | $21,476.80 |
DisclosureSEC source: 0000899243-22-015762 · doc4.xml · nonDerivative · entry 2 Ambrose Kristen · CIK 0001856587 · SVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,683 F1 · kind: Transaction made pursuant to Ms. Ambrose's company approved trading plan under Rule 10b5-1. F2 · price: Ms. Ambrose undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $268.46 (range $268.05 to $268.86). Read SEC document |
| April 25, 2022 Filed Apr 27, 2022 20:05 UTC |
Ambrose KristenSVP & Chief Accounting Officer
|
SaleCommon Stock | 60 | $267.37 | $16,042.20 |
DisclosureSEC source: 0000899243-22-015762 · doc4.xml · nonDerivative · entry 1 Ambrose Kristen · CIK 0001856587 · SVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,763 F1 · kind: Transaction made pursuant to Ms. Ambrose's company approved trading plan under Rule 10b5-1. F2 · price: Ms. Ambrose undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F3 · price: Open market sales reported on this line occurred at a weighted average price of $267.37 (range $266.86 to $267.85). Read SEC document |
| April 18, 2022 Filed Apr 20, 2022 20:05 UTC |
Lee YuchunDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $81.54 | $0.00 |
DisclosureSEC source: 0000899243-22-015163 · doc4.xml · derivative · entry 6 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,000 shares Expires 2023-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Fully vested. Read SEC document |
| April 18, 2022 Filed Apr 20, 2022 20:05 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 119 | $286.80 | $34,129.20 |
DisclosureSEC source: 0000899243-22-015163 · doc4.xml · nonDerivative · entry 5 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,875 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $286.80 (range $286.68 to $286.82). Read SEC document |
| April 18, 2022 Filed Apr 20, 2022 20:05 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 491 | $285.16 | $140,013.56 |
DisclosureSEC source: 0000899243-22-015163 · doc4.xml · nonDerivative · entry 4 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,994 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $285.16 (range $284.88 to $285.63). Read SEC document |
| April 18, 2022 Filed Apr 20, 2022 20:05 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 1,008 | $284.06 | $286,332.48 |
DisclosureSEC source: 0000899243-22-015163 · doc4.xml · nonDerivative · entry 3 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,485 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $284.06 (range $283.72 to $284.46). Read SEC document |
| April 18, 2022 Filed Apr 20, 2022 20:05 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 382 | $282.70 | $107,991.40 |
DisclosureSEC source: 0000899243-22-015163 · doc4.xml · nonDerivative · entry 2 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,493 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F3 · price: Open market sales reported on this line occurred at a weighted average price of $282.70 (range $282.40 to $283.15). Read SEC document |
| April 18, 2022 Filed Apr 20, 2022 20:05 UTC |
Lee YuchunDirector
|
Exercise / conversionCommon Stock | 2,000 | $81.54 | $163,080.00 |
DisclosureSEC source: 0000899243-22-015163 · doc4.xml · nonDerivative · entry 1 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,875 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 14, 2022 Filed Apr 18, 2022 20:05 UTC |
SACHS BRUCE IDirector
|
GrantDeferred Stock Units · Derivative | 151.17 | $289.41 | $43,750.11 |
DisclosureSEC source: 0000899243-22-014960 · doc4.xml · derivative · entry 1 SACHS BRUCE I · CIK 0001197036 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,823.508 Underlying: Common Stock · 151.17 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death. F1 · derivative.exercise_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death. F1 · derivative.expiration_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death. Read SEC document |
| April 14, 2022 Filed Apr 18, 2022 20:05 UTC |
MCKENZIE DIANADirector
|
GrantDeferred Stock Units · Derivative | 95.021 | $289.41 | $27,500.03 |
DisclosureSEC source: 0000899243-22-014961 · doc4.xml · derivative · entry 1 MCKENZIE DIANA · CIK 0001754648 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 888.685 Underlying: Common Stock · 95.021 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death. F1 · derivative.exercise_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death. F1 · derivative.expiration_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death. Read SEC document |
| April 14, 2022 Filed Apr 18, 2022 20:05 UTC |
Lee YuchunDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $81.54 | $0.00 |
DisclosureSEC source: 0000899243-22-014962 · doc4.xml · derivative · entry 6 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2023-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Fully vested. Read SEC document |
| April 14, 2022 Filed Apr 18, 2022 20:05 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 400 | $291.18 | $116,472.00 |
DisclosureSEC source: 0000899243-22-014962 · doc4.xml · nonDerivative · entry 5 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,875 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $291.18 (range $290.80 to $291.64). Read SEC document |
| April 14, 2022 Filed Apr 18, 2022 20:05 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 400 | $289.84 | $115,936.00 |
DisclosureSEC source: 0000899243-22-014962 · doc4.xml · nonDerivative · entry 4 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,275 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $289.84 (range $289.69 to $289.96). Read SEC document |
| April 14, 2022 Filed Apr 18, 2022 20:05 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 252 | $288.92 | $72,807.84 |
DisclosureSEC source: 0000899243-22-014962 · doc4.xml · nonDerivative · entry 3 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,675 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $288.92 (range $288.51 to $289.24). Read SEC document |
| April 14, 2022 Filed Apr 18, 2022 20:05 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 948 | $287.87 | $272,900.76 |
DisclosureSEC source: 0000899243-22-014962 · doc4.xml · nonDerivative · entry 2 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,927 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F3 · price: Open market sales reported on this line occurred at a weighted average price of $287.87 (range $287.49 to $288.26). Read SEC document |
| April 14, 2022 Filed Apr 18, 2022 20:05 UTC |
Lee YuchunDirector
|
Exercise / conversionCommon Stock | 2,000 | $81.54 | $163,080.00 |
DisclosureSEC source: 0000899243-22-014962 · doc4.xml · nonDerivative · entry 1 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,875 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 13, 2022 Filed Apr 14, 2022 20:35 UTC |
Lee YuchunDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $81.54 | $0.00 |
DisclosureSEC source: 0000899243-22-014804 · doc4.xml · derivative · entry 16 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 2,000 shares Expires 2023-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F14 · derivative.exercise_date: Fully vested. Read SEC document |
| April 13, 2022 Filed Apr 14, 2022 20:35 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 354 | $291.12 | $103,056.48 |
DisclosureSEC source: 0000899243-22-014804 · doc4.xml · nonDerivative · entry 14 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,875 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F13 · price: Open market sales reported on this line occurred at a weighted average price of $291.12 (range $290.80 to $291.42). Read SEC document |
| April 13, 2022 Filed Apr 14, 2022 20:35 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 200 | $290.17 | $58,034.00 |
DisclosureSEC source: 0000899243-22-014804 · doc4.xml · nonDerivative · entry 13 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,229 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F12 · price: Open market sales reported on this line occurred at a weighted average price of $290.17 (range $289.72 to $290.62). Read SEC document |
| April 13, 2022 Filed Apr 14, 2022 20:35 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 400 | $288.55 | $115,420.00 |
DisclosureSEC source: 0000899243-22-014804 · doc4.xml · nonDerivative · entry 12 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,429 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F11 · price: Open market sales reported on this line occurred at a weighted average price of $288.55 (range $288.23 to $289.11). Read SEC document |
| April 13, 2022 Filed Apr 14, 2022 20:35 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 200 | $287.42 | $57,484.00 |
DisclosureSEC source: 0000899243-22-014804 · doc4.xml · nonDerivative · entry 11 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,829 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F10 · price: Open market sales reported on this line occurred at a weighted average price of $287.42 (range $287.02 to $287.83). Read SEC document |
| April 13, 2022 Filed Apr 14, 2022 20:35 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 300 | $286.24 | $85,872.00 |
DisclosureSEC source: 0000899243-22-014804 · doc4.xml · nonDerivative · entry 10 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,029 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F9 · price: Open market sales reported on this line occurred at a weighted average price of $286.24 (range $285.99 to $286.60). Read SEC document |
| April 13, 2022 Filed Apr 14, 2022 20:35 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 228 | $284.90 | $64,957.20 |
DisclosureSEC source: 0000899243-22-014804 · doc4.xml · nonDerivative · entry 9 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,329 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F8 · price: Open market sales reported on this line occurred at a weighted average price of $284.90 (range $284.66 to $284.95). Read SEC document |
| April 13, 2022 Filed Apr 14, 2022 20:35 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 300 | $283.73 | $85,119.00 |
DisclosureSEC source: 0000899243-22-014804 · doc4.xml · nonDerivative · entry 8 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,557 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F7 · price: Open market sales reported on this line occurred at a weighted average price of $283.73 (range $283.30 to $284.10). Read SEC document |
| April 13, 2022 Filed Apr 14, 2022 20:35 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 18 | $281.49 | $5,066.82 |
DisclosureSEC source: 0000899243-22-014804 · doc4.xml · nonDerivative · entry 7 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,857 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. Read SEC document |
| April 13, 2022 Filed Apr 14, 2022 20:35 UTC |
Lee YuchunDirector
|
Exercise / conversionCommon Stock | 2,000 | $81.54 | $163,080.00 |
DisclosureSEC source: 0000899243-22-014804 · doc4.xml · nonDerivative · entry 6 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,875 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 13, 2022 Filed Apr 14, 2022 20:35 UTC |
LEIDEN JEFFREY MDirector · Executive Chairman
|
SaleCommon Stock | 15,789 | $289.04 | $4,563,652.56 |
DisclosureSEC source: 0000899243-22-014805 · doc4.xml · nonDerivative · entry 1 LEIDEN JEFFREY M · CIK 0001242825 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,160 F1 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1. F2 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F3 · price: Open market sales reported on this line occurred at a weighted average price of $289.04 (range $289.00 to $289.58). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.